We aimed to characterize the influence of acute myocardial infarction (AMI) on the metabolic activity of the bone marrow (BM) and on the composition and functional activity of BM-derived mononuclear cells (BMC). Acute ischaemia or other stressors induce the mobilization of progenitor cells from the BM stem cell niche. The effect of AMI on the numbers and functional activity of cells within the BM is unknown.
Introduction
Although reperfusion therapy has significantly improved prognosis of patients with acute myocardial infarction (AMI), the development of post-infarction heart failure remains a major challenge, particularly in patients with large AMIs. 1, 2 Cell therapy may provide an attractive novel option to beneficially interfere with left ventricular (LV) remodelling processes, and thereby to prevent the † These authors contributed equally to this work.
development of post-infarction heart failure. 3 In experimental studies, administration of various types of cells including circulating endothelial progenitor cells, bone marrow (BM)-derived mononuclear cells (BMC), CD34 + cells, mesenchymal stem cells, adipose tissue-derived cells, and cardiac stem cells lead to improvement of neovascularization and cardiac function. 4 -7 In contrast, clinical trials provided rather heterogeneous results so far, and the overall effect of cell therapy on improvement of ejection fraction (EF) has been modest (on average 2.5 -3% increase in LVEF). 8, 9 The reasons for the discrepancies between experimental studies and clinical trials as well as for the heterogeneous responses within different clinical trials are unclear. While previous studies have shown that cell isolation protocols 10 and cell type and functionality 11 -13 affect neovascularization capacity of BM-derived cells, there are no clinical studies assessing potential alterations in the BM niche after AMI, which may have an impact on the composition and functional activity of BM-resident mononuclear cells used for cell therapy. Indeed, several experimental and clinical studies demonstrated the release of several subtypes of pro-angiogenic cells, haematopoietic progenitor cells, and very small embryonic like stem cells into the peripheral blood (PB) after AMI, 14 -17 suggestive of an activation of the BM niche. Therefore, it was the aim of the current study to investigate the metabolic activity of the BM and the characteristics of BM-derived mononuclear cells in patients after AMI. Experimental mouse models were used to confirm these data and to provide insights into the putative underlying signalling events.
Methods

Study population and protocol
Patients with an acute ST elevation myocardial infarction successfully reperfused with stent implantation with a residual significant LV regional wall motion abnormality (LVEF ≤45% by visual estimate at the time of reperfusion therapy) were included in the REPAIR-AMI trial (clinicaltrials.gov, number NCT00279175). A total of 204 patients were randomized to receive either intracoronary infusion of placebo medium or BMC (for detailed baseline characteristics, see Schächinger et al.
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). Cell processing and quality controls were performed in a central core lab, and all measures were performed immediately after the BMC isolation process. Further details of cell preparation and administration have been described previously. 10, 19 For analysis of the BM metabolic activity by F-18-fluorodeoxyglucosepositron emission tomography (FDG-PET) imaging, patients included in the TOPCARE-AMI trial or the TOPCARE-CHD trial were assessed. 20, 21 The Ethics Review Board of the Hospital of the Johann Wolfgang Goethe University of Frankfurt, Germany, approved the protocols, and the studies were conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from each patient.
F-18-fluorodeoxyglucose -positron emission tomography
F-18-fluorodeoxyglucose-positron emission tomography was performed with a whole-body PET scanner (ECAT EXACT 47, Siemens CTI). 22 Then, mean signal intensities (MSI, presented as mean + SEM) were calculated after focusing the region of interest above the thoracic spine of each patient.
Flow cytometry analysis of bone marrow-derived mononuclear cells in the REPAIR-AMI trial
After Ficoll density gradient centrifugation, BMC were analysed by FACS. For the enumeration of BM cell populations, we used directly conjugated antibodies against human CD45 (FITC-labelled, BD Pharmingen), CD34 (PE-labelled; BD Pharmingen), CD133 (APC-labelled; Miltenyi), and KDR (PE-labelled; R&D Systems). Gating was performed according to the ISHAGE guideline. 23 
Assessment of haematopoietic colonies
Bone marrow-derived mononuclear cells (1 × 10 5 per dish) were seeded in methylcellulose plates (Methocult GF H4534; StemCell). Plates were studied under phase-contrast microscopy, and colonyforming units (CFU; colonies .50 cells) were counted after 14 days of incubation at 378C by an independent investigator. Colony-forming units were examined in duplicates.
Assessment of invasion capacity of bone marrow-derived mononuclear cells
A total of 1 × 10 6 BMC were resuspended in 250 mL X-vivo 10 medium and placed in the upper chamber of a modified Boyden chamber filled with Matrigel (BioCoat invasion assay, 8 mm pore size, Becton-Dickinson). Then, the chamber was placed in a 24-well culture dish containing 500 mL EBM medium. For stimulation of invasion, 100 ng/mL SDF-1 was added in the lower chamber. After incubation for 24 h at 378C, transmigrated cells were counted by independent investigators. Invasion assays were run in duplicates.
Animal experiments
Myocardial infarction, assessment of initial infarct size, and cell collection
Myocardial infarction was induced by permanent ligation of left coronary artery in 10-to 12-week-old C57BL/6 male mice. Echocardiography was performed using a high-resolution echocardiographic system (Vevo770, VisualSonics, Toronto, ON, Canada) equipped with an RMV 707B transducer. Wall motion score index was assessed using a 16-segment model. 24 Infarcted mice were euthanized on Days 3, 5, and 7 after induction of myocardial infarction. Non-treated 10-to 12-week-old C57BL/6 male mice were served as a control. The PB from mice was drawn from the inferior vena cava. Then, BM cells were aseptically collected from the femurs and tibias. Bone marrowderived mononuclear cells were obtained by Ficoll density gradient centrifugation.
Flow cytometry
Peripheral blood-derived cells or BMC were stained with biotinlabelled lineage cell detection cocktail, PE-labelled anti-c-kit mAb, and APC-labelled anti-Sca-1 mAb followed by staining with FITC-labelled avidin, followed by haemolysis with FACS lysing solution (8 min for PB and 5 min for BMC). The samples were analysed by a flow cytometer, FACS Canto II device (BD).
Colony-forming unit assay
Bone marrow-derived mononuclear cells (2 × 10 4 per dish) were seeded in methylcellulose plates (MethoCult GF M3434 Stem Cell Technology). Plates were studied under phase-contrast microscopy after 7 days of incubation.
Polymerase chain reaction
RNA from total BM was isolated (RNA minikit, Qiagen, Hilden) and reverse transcribed (Applied Biosystems, Foster City, CA, USA). Polymerase chain reaction was performed on the cDNA using the following primers: mouse Axin-2 sense 5
′ -GAGACCACCTGGTGCTCAGTGTAG-3 ′ (GAPDH band 511 bp). Polymerase chain reaction reagents were obtained from Invitrogen (Karlsruhe, Germany). Polymerase chain reaction products were analysed on agarose gel and performed by the Sybr Green Realtime protocol.
X-gal staining of the TOP-GAL mice TOP-GAL transgenic mice 25 report sites of canonical Wnt signalling in the BM. The TOP-GAL transgene b-galactosidase gene is driven by an LEF/TCF and b-catenin responsive promoter. On Day 3 after AMI, mice were sacrificed and perfused with 2% paraformaldehyde (PFA) in phosphate-buffered saline (PBS). Then, femora and tibiae were removed, cleaned, and again fixed in 2% PFA for 30 min at room temperature and for another 30 min at 378C. After washing twice with PBS at 378C, the bones were incubated in EDTA Tris solution (pH 6.8 -7.0) at 378C for 48 h. Bones were then rinsed with H 2 O for 30 min, followed by storing in PBS for 7 days at 48C. Then, bones were rinsed in washing solution (2 mM MgCl and 0.02% NP-40 in PBS), fixed in fixative solution (1% PFA, 2 mM MgCl, 5 mM EGTA, and 0.02% NP-40 in PBS + 0.2% glutaraldehyde) for 60 min at 378C. After washing three times for 60 min in washing solution at 378C, bones were incubated in staining solution (5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl, 0.01% sodium deoxycholate, 0.02% NP-40, and 1 mg/mL X-gal) overnight. Finally, bones were washed with PBS, fixed again for 2 h in 4% PFA at 48C, and kept in 10% formaldehyde overnight, prior to preparing paraffin sections and counterstaining with eosin.
Statistical analysis
If not stated otherwise, data are shown as mean + SEM. Statistical comparisons were made by the non-parametric Wilcoxon two-sample test (paired analysis), Friedman's test, or the non-parametric MannWhitney U-test. P-value for trend was calculated with the ANOVA model. Adjustment of the patients' cell parameters for individual haemoglobin levels was performed by division of the parameter by the corresponding haemoglobin value (measured in mg/dL). Statistical significance was assumed, if P , 0.05. All reported P-values are two-sided. All statistical analysis was performed with SPSS (Version 17.0, SPSS Inc.).
Results
Acute myocardial infarction enhances metabolic activity of the bone marrow
In order to analyse the impact of AMI on the metabolic activity of the BM, we focused the region of interest of FDG-PET assessment above the thoracic spine and compared the MSI of patients with revascularized AMI with the MSI of patients with chronic postinfarction heart failure at least 3 months after AMI and an open infarct-related artery. Table 1 shows the different patient characteristics of the two cohorts. Of note, patients with AMI were younger compared with patients with post-infarction heart failure and had a better LV function and a smaller number of diseased vessels. As shown in Figure 1A , AMI is associated with a significantly greater uptake of labelled glucose compared with the uptake in chronic post-infarction heart failure patients, indicating increased metabolic activity of the BM following AMI. Figure 1B and C shows examples of two patients with either low ( Figure 1B ) or high ( Figure 1C ) glucose uptake in the thoracic spine.
Changes within the mononuclear bone marrow cell subpopulations according to the time interval from the acute myocardial infarction
Patients being included in the REPAIR-AMI trial underwent BM aspiration between 2 and 8 days after the acute event. Timing of BM aspiration was classified into three groups reflecting early Table 2 . Of note, there were no significant differences with respect to age, LVEF reflecting infarct size, risk factor profile, and initial treatment regime (PCI vs. thrombolysis).
Although the total number of BM-derived mononuclear cells in the final cell preparation did not demonstrate any statistically significant changes with increasing time interval from the AMI (Figure 2A, left panels) , the percentage of CD34 + CD45 + haematopoetic progenitor cells (HPC) increased significantly over time. Likewise, the CD133 + CD45 + subpopulation increased significantly. Functionality of the isolated cells, as assessed by CFU capacity and their invasive capacity towards the physiological chemoattractant SDF-1, remained unchanged ( Figure 2B , left panels). In order to exclude that anaemia, as an established activator of the BM, is responsible for the observed effects, we normalized the cell numbers and subpopulations as well as the cell functionality parameters to the individual PB haemoglobin levels at the time of BM aspiration ( Figure 2A and B, right panels). However, the regulation of progenitor cell numbers and functional activity were similar after adjustment for potential blood loss during the coronary intervention performed to acutely re-open the infarct-related artery. Together, these clinical data demonstrate that AMI activates the BM, increases the metabolic activity of the BM, and increases the number of CD34 + and CD133 + cells obtained from the BM aspirates in humans.
Bone marrow activation in experimental models
In order to provide insights into putative underlying signalling mechanisms, we used a mouse myocardial infarction model to confirm the results derived from the clinical trial. Induction of AMI was associated with a significant deterioration of cardiac function ( Figure 3A) and stimulated the mobilization of c-kit + Sca-1 + lin-(KSL) cells into the circulation ( Figure 3B ). In parallel to the profound and efficient mobilization of KSL cells into the circulation during the first week after AMI, the number of KSL cells significantly increased in the BM at Day 7. Moreover, the number of GM-CFU increased, albeit with a slightly different kinetic. These data indicate that mobilized KSL cells are reconstituted in response to the stress signalling imposed by AMI reflecting an activated BM niche. Haematopoetic progenitor cell proliferation and expansion is controlled by morphogens of the Wnt family. 26 Therefore, we addressed whether Wnt signalling is activated in the BM after AMI. To identify active Wnt signalling in the BM, we used TOP-GAL transgenic mice carrying a b-galactosidase gene driven by an LEF/TCF/b-catenin responsive promoter, which reports the status of the transcriptional activity of b-catenin, the product of canonical Wnt signalling. 25 After induction of AMI, LacZ expression-indicating active Wnt signalling-increased in the BM ( Figure 4A) . Consistently, the prototypical Wnt targets Axin-2 (conductin) 27 and Jagged-1 28 were increased timedependently in BMC after AMI ( Figure 4B ). Moreover, RankL, which has been reported to be suppressed by canonical Wnt signalling in BM stromal cells, 29 demonstrated a time-dependent down-regulation in the BM cells following AMI ( Figure 4C ). These data demonstrate that AMI indeed induces active canonical Wnt signalling in the mouse mononuclear BM cells. In addition, induction of acute hind limb ischaemia in mice also resulted in activation of the canonical Wnt signalling pathway as evidenced by an increased LacZ expression in the BM of TOP-GAL transgenic mice (data not shown).
Wnt signalling activated human bone marrow-derived mononuclear cell ex vivo 20 (22) 11 (13) 3 (12) Active smoker, n (%) 37 (40) 45 (52) isolated human BM mononuclear cells. As illustrated in Figure 5 , the addition of Wnt3a dose-dependently increased both the CFU capacity and the migratory capacity of the cells towards the chemoattractant SDF-1, indicative of direct activation of human BM-derived mononuclear cells by the Wnt signalling pathway.
Discussion
The data of the present study provide first insights into the regulation of metabolic activity of the BM and BM mononuclear cell number and function in patients with AMI. Although various previous experimental and clinical studies showed that AMI stimulates the mobilization of HPC and several subtypes of vasculogenic cells, the influence of AMI on the progenitor cells residing in the BM has not been studied. Our data suggest that AMI increases the number of CD34 + and CD133 + BM-resident progenitor cells within 7 days. We confirmed the results in an experimental study in mice and demonstrate that KSL cells (the murine functional equivalent to human CD34 + cells) are also augmented in the BM after AMI, despite a profound mobilization. Moreover, in the animal experiments, we demonstrate that ischaemic stress activates canonical Wnt signalling in the BM, a well-established signalling mechanism to promote HPC proliferation and expansion. Previous studies have shown that circulating CD34 + and CD133 + cell levels significantly increase in patients with AMI, peaking around 7 days after ischaemic injury. 15, 30 Importantly, the extent of initial mobilization of CD34 + cells was shown to be an independent predictor of a more favourable remodelling following AMI. 31 In addition, mobilization of CD34 + cells by granulocyte colony-stimulating factor (G-CSF) is more efficient in patients with AMI compared with patients with old myocardial infarction. 32 Thus, we postulated that AMI is associated with an activation of the BM in order to replenish the mobilized cells. Indeed, in experimental studies, an increase in cell proliferation within the BM has also previously been shown for G-CSF, which induced a proliferative response overcompensating for the loss of mobilized cells in the BM leading to a net increase in KSL cells. 33 The observed augmentation of metabolic activity of the BM as determined by PET in patients after AMI is consistent with an increase in proliferation of BM progenitor cells. Mechanistically, proliferation of HPC is regulated by a variety of stimuli including canonical Wnt signalling. Wnts can directly activate HPC, but also play a crucial role in the BM stem cell niche. Although Wnts act in a context-dependent manner, most of the studies suggest that transient activation of canonical Wnt signalling promotes HPC proliferation and expansion. 26 The mechanisms by which AMI stimulates Wnt signalling in the BM are unclear. However, one may speculate that catecholaminergic activationas it occurs in patients with AMI
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-plays a role in mediating the signals. Catecholamines were shown to stimulate Wnt signalling in the BM and lead to an increase in CFU numbers that was blocked by a Wnt antagonists. 35 Additionally, a variety of cytokines, which are elevated following AMI, such as vascular endothelial growth factor (VEGF) or G-CSF, regulate HPC proliferation. 36 However, the circulating levels of the cytokines were not associated with the number of CD34 + cells in the BM and VEGF concentrations did not increase in the BM of rats 3 days after AMI. 37 Thus, the causal mechanisms underlying the increase in progenitor cells in the BM after AMI remain to be elucidated. Finally, the data of the present study may provide additional insights with respect to the optimal timing of cell therapy. Retrospective analysis of the REPAIR-AMI study showed that patients receiving infusion of BMC at Day .5 showed a significantly better improvement of LVEF compared with patients, who were treated at earlier time points. 18 Although these data have not yet been prospectively confirmed, we speculate that the local environment and the homing signals in the infarcted heart might have favoured engraftment of the infused progenitor cells at later time points. The data of the present study now offer another possibility, namely that the number of vasculogenic progenitor cells in the BM is higher at later time points and that changes in the cell product infused in the patients may have influenced the outcome. However, we cannot exclude that the time course of BM activation in mouse and man may differ. Therefore, the hypotheses generated in the present study clearly have to be further tested in experimental and clinical studies. Ongoing clinical trials, which test for the effect of early vs. late treatment of patients with AMI with BMC and which simultaneously carefully control for cell functionality in core laboratories (The TIME study, NCT00684021; and The late TIME study, NCT00684060), will likely provide answers to some of these open questions.
Limitations
The current interpretation of patient data is limited by the fact that FDG-PET activity and BM-derived cell characteristics were obtained from different patient cohorts, thus precluding direct correlative analyses between BM metabolism and cell proliferation. Likewise, the grouping of patients with respect to the timing of BM aspiration was performed post hoc in the REPAIR-AMI trial. The distribution of the time points of BM aspiration post-myocardial infarction made it impossible to generate three groups with comparable sample size. Therefore, the time intervals were chosen within the limitations provided by the study protocol.
Funding
This study was supported by the Deutsche Forschungsgemeinschaft (SFB 834; project B6 to B.A. and A.M.Z.), the Excellence Cluster Exc 147-1, and the LOEWE Center for Cell and Gene Therapy (state of Hesse). 
